# Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer

> **NCT00902954** · PHASE3 · UNKNOWN · sponsor: **Fudan University** · enrollment: 540 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** anastrozole
- **DRUG:** letrozole
- **DRUG:** exemestane

## Key facts

- **NCT ID:** NCT00902954
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2010-06
- **Final completion:** 2011-06
- **Target enrollment:** 540 (ESTIMATED)
- **Last updated:** 2009-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00902954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00902954, "Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00902954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*